Brenntag stock after-hours at EUR 59.36: plus 1.19 percent versus Lang & Schwarz prior close
Published on 10/05/2026 at 19:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Brenntag traded after-hours at EUR 59.36 at 7:05 p.m. CEST on October 5, 2026, according to Lang & Schwarz. The price was up 1.19 percent versus the prior close of EUR 58.66 at Lang & Schwarz.
Trading day
The Lang & Schwarz indication stood above the previous trading day's close after the Xetra session. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Brenntag stock.
Global biopharma partnership
On September 29, 2026, Brenntag and dsm-firmenich announced a global distribution agreement and long-term strategic partnership for high-purity, GMP-grade vitamins. The agreement grants Brenntag exclusive distribution rights for dsm-firmenich’s Biond portfolio across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, according to Brenntag.
The portfolio comprises eight products under the BYPHAR powered by Biond brand. Brenntag said the products are intended for cell culture media, feed media and upstream bioprocessing. The public presentation is scheduled for October 7, 2026, at CPHI in Milan, the company said in the same release.
Bond placement
In a September 14, 2026 release, Brenntag reported the successful placement of a EUR 500 million bond. The bond was issued by Brenntag Finance B.V., has a seven-year maturity and carries a 4.25 percent coupon. The issue price was 99.626 percent, and the net proceeds are intended for general corporate purposes, according to Brenntag.
